Cargando…
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Bioprosthetic Valves—A Systematic Review and Meta-analysis
Oral anticoagulation is recommended for patients with atrial fibrillation and an elevated stroke risk. Direct oral anticoagulants (DOACs) are generally preferred over vitamin K antagonists. Nonetheless, there controversy persists regarding whether DOACs should be used in patients with atrial fibrill...
Autores principales: | Ruzieh, Mohammed, Wolbrette, Deborah L., Naccarelli, Gerald V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MediaSphere Medical
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712023/ https://www.ncbi.nlm.nih.gov/pubmed/34970469 http://dx.doi.org/10.19102/icrm.2021.121202 |
Ejemplares similares
-
Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation
por: O'Callaghan, Marissa, et al.
Publicado: (2018) -
Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve
por: Moon, Inki, et al.
Publicado: (2022) -
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010) -
Safety and efficacy of direct oral anticoagulants in bioprosthetic valves: A systematic review and meta-analysis
por: Bakr, Lubna, et al.
Publicado: (2023) -
Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Maraj, Ilir, et al.
Publicado: (2018)